BETA-2
MOLECULAR TARGETBeta-2 adrenergic receptor (human)
BETA-2 (Beta-2 adrenergic receptor (human)) is targeted by 14 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting BETA-2
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on | 1.39 | 3 |
| 2 | Levalbuterol | 1.10 | 2 |
| 3 | Levalbuterol | 1.10 | 2 |
| 4 | Carvedilol | 1.10 | 2 |
| 5 | Clenbuterol | 1.10 | 2 |
| 6 | Epinephrine | 1.10 | 2 |
| 7 | Ergotamine | 1.10 | 2 |
| 8 | Labetalol | 1.10 | 2 |
| 9 | Levobunolol | 1.10 | 2 |
| 10 | Lisuride | 1.10 | 2 |
| 11 | Pindolol | 1.10 | 2 |
| 12 | Propranolol | 1.10 | 2 |
| 13 | Sotalol | 1.10 | 2 |
| 14 | Timolol | 1.10 | 2 |
About BETA-2 as a Drug Target
BETA-2 (Beta-2 adrenergic receptor (human)) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 14 compounds with documented BETA-2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
BETA-2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.